FindTrial
Sign In

Analgesic effectiveness of wound infiltration with bupivacaine and a mixture of bupivacaine and tramadol for postoperative pain management among participants undergoing elective cesarean section under spinal anesthesia at dilla university general hospital, 2023: a double-blind randomized controlled trial

Analgesic effectiveness of wound infiltration with bupivacaine and a mixture of bupivacaine and tramadol for postoperative pain management among participants undergoing elective cesarean section under spinal anesthesia at Dilla university general hospital, 2023: a double-blind randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
PACTR
Registry ID
PACTR202310525672884
Enrollment
60
Registered
2023-10-13
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female Anaesthesia

Interventions

Bupivacaine alone
Bupivacaine with tramadol

Sponsors

Dilla University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Pregnant mothers between 18 and 45 ? ASA class =II

Exclusion criteria

Exclusion criteria: ? Patients with known allergies to bupivacaine and tramadol ? History of alcohol usage, opiate or other drug abuse ? Pregnant mothers who diagnosed with Chronic pain ? Pregnant mothers with systemic diseases like renal impairment, chronic liver disease, chronic obstructive pulmonary disease, and cardiac disease ? Pregnant mothers with pre-eclampsia, eclampsia ? Spinal anesthesia with adjuvants ? Operation other than the lower uterine segment incision ? Pregnant mothers taking opioids preoperatively

Design outcomes

Primary

MeasureTime frame
Postoperative total Analgesia consumption in the first 24 hours Time to first analgesic request in minutes Postoperative Pain severity (NRS score (0–10 cm))—

Secondary

MeasureTime frame
Postoperative nausea and vomiting (3-point scale)—

Countries

Ethiopia

Contacts

Public ContactHailemariam Getachew Tesema

Dilla University

hailemariamgetachew23@gmail.com+251912982067

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026